(Q54144526)

25 May 2018

title

MDR1 gene expression and drug resistance of AML cells. (English)

1 reference

25 May 2018

author

Peter Hokland

6

1 reference

25 May 2018

author name string

Nørgaard JM

1

1 reference

25 May 2018

Bukh A

2

1 reference

25 May 2018

Langkjer ST

3

1 reference

25 May 2018

Clausen N

4

1 reference

25 May 2018

Palshof T

5

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

25 May 2018

British Journal of Haematology

published in

1 reference

25 May 2018

volume

100

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

534-540

1 reference

25 May 2018

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

The drug resistance-related protein LRP is the human major vault protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

Modifiers of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

Ubiquitous, but variable, expression of two alternatively spliced mRNAs encoding mouse homologues of transcription factors E47 and E12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

RELATION OF BLAST CELL SURVIVAL AND PROLIFERATION TO CHEMOTHERAPY RESISTANCE IN AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00593.X

10.1046/J.1365-2141.1998.00593.X

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018